Literature DB >> 26209378

Persistent viremia and urine shedding of tick-borne encephalitis virus in an infected immunosuppressed patient from a new epidemic cluster in North-Eastern Italy.

Ilaria Caracciolo1, Matteo Bassetti2, Giorgio Paladini3, Roberto Luzzati4, Daniela Santon1, Maria Merelli2, Giovanni De Sabbata3, Tea Carletti5, Alessandro Marcello6, Pierlanfranco D'Agaro7.   

Abstract

A persistent tick-borne encephalitis virus infection in an immune-suppressed patient is presented. Such an unusual clinical case offers the unique chance of detecting persistent viremia associated to the erythrocyte fraction and shedding of the virus in the urine for more than six weeks. The infection occurred in a new area of the Friuli Venezia-Giulia region (North Eastern Italy) where two additional cases are also being reported.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Friuli-Venezia Giulia region; Immuno-compromized host; Italy; Persistent infection; Real-time PCR; Sequencing; TBEV; Tick-borne encephalitis; Trieste; Virus isolation

Mesh：

Substances：

Year:  2015        PMID： 26209378     DOI： 10.1016/j.jcv.2015.05.019

Source DB:  PubMed          Journal:  J Clin Virol        ISSN： 1386-6532            Impact factor:   3.168


  9 in total

1.  Switch-on the LAMP to spot Zika.

Authors:  Erick Mora-Cárdenas; Alessandro Marcello
Journal:  Ann Transl Med       Date:  2017-12

2.  Two Cases of Severe Tick-Borne Encephalitis in Rituximab-Treated Patients in Germany: Implications for Diagnosis and Prevention.

Authors:  Philipp A Steininger; Tobias Bobinger; Wenke Dietrich; De-Hyung Lee; Michael Knott; Christian Bogdan; Klaus Korn; Roland Lang
Journal:  Open Forum Infect Dis       Date:  2017-09-26       Impact factor: 3.835

3.  Contact-dependent transmission of Langat and tick-borne encephalitis virus in type I interferon receptor-1 deficient mice.

Authors:  Sarah Schreier; Kristin Cebulski; Andrea Kröger
Journal:  J Virol       Date:  2021-01-27       Impact factor: 5.103

4.  Diagnosing tick-borne encephalitis: a re-evaluation of notified cases.

Authors:  Malin Veje; Marie Studahl; Maja Johansson; Patrik Johansson; Peter Nolskog; Tomas Bergström
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-11-29       Impact factor: 3.267

5.  Pathological modeling of TBEV infection reveals differential innate immune responses in human neurons and astrocytes that correlate with their susceptibility to infection.

Authors:  Mazigh Fares; Marielle Cochet-Bernoin; Gaëlle Gonzalez; Claudia N Montero-Menei; Odile Blanchet; Alexandra Benchoua; Claire Boissart; Sylvie Lecollinet; Jennifer Richardson; Nadia Haddad; Muriel Coulpier
Journal:  J Neuroinflammation       Date:  2020-03-03       Impact factor: 8.322

6.  T-Cell Immunoglobulin and Mucin Domain 1 (TIM-1) Is a Functional Entry Factor for Tick-Borne Encephalitis Virus.

Authors:  Xiaowei Zhang; Cuiqin Liang; Hanzhong Wang; Zhengyuan Guo; Heng Rong; Jingdi Pan; Wei Li; Rongjuan Pei; Xinwen Chen; Zhiping Zhang; Xian-En Zhang; Zongqiang Cui
Journal:  mBio       Date:  2022-01-25       Impact factor: 7.867

7.  The Detectability of the Viral RNA in Blood and Cerebrospinal Fluid of Patients with Tick-Borne Encephalitis.

Authors:  Sambor Grygorczuk; Justyna Dunaj-Małyszko; Piotr Czupryna; Artur Sulik; Kacper Toczyłowski; Agnieszka Siemieniako-Werszko; Agnieszka Żebrowska; Sławomir Pancewicz; Anna Moniuszko-Malinowska
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

Review 8.  Tick-Borne Flaviviruses and the Type I Interferon Response.

Authors:  Richard Lindqvist; Arunkumar Upadhyay; Anna K Överby
Journal:  Viruses       Date:  2018-06-21       Impact factor: 5.048

9.  Comprehensive response to Usutu virus following first isolation in blood donors in the Friuli Venezia Giulia region of Italy: Development of recombinant NS1-based serology and sensitivity to antiviral drugs.

Authors:  Ilaria Caracciolo; Erick Mora-Cardenas; Chiara Aloise; Tea Carletti; Ludovica Segat; Maria Sole Burali; Alexsia Chiarvesio; Vivianna Totis; Tatjana Avšič-Županc; Eloise Mastrangelo; Giuseppe Manfroni; Pierlanfranco D'Agaro; Alessandro Marcello
Journal:  PLoS Negl Trop Dis       Date:  2020-03-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.